Thank you to the person who bought my share this morning .. lol![]()
sold at a loss of 25% roughly....![]()
company has $5m employee expense (in addition to research) for the revenue of $5m and NTA down to 3c from 6c previous financial year ... with 2 product sitting on shelf fully approved by FDA for almost a year but not on market ... compelled me to recover my 75% of my principal ... IMO... Good luck to those hanging in there ... !
- Forums
- ASX - By Stock
- ACR
- Ann: Appendix 4E and FY22 Annual Report
ACR
acrux limited
Add to My Watchlist
0.00%
!
2.0¢

Ann: Appendix 4E and FY22 Annual Report, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.155M |
Open | High | Low | Value | Volume |
2.0¢ | 2.0¢ | 1.9¢ | $13.65K | 683.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 571000 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 234041 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 571000 | 0.019 |
3 | 381800 | 0.018 |
3 | 472000 | 0.017 |
1 | 66732 | 0.015 |
1 | 70000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 234041 | 2 |
0.021 | 80630 | 1 |
0.022 | 204574 | 4 |
0.023 | 115126 | 4 |
0.024 | 306848 | 8 |
Last trade - 12.14pm 18/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online